Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Genomic Translation

    Poster image for Public Health Assessment of Genetic Tests for Screening and Prevention
    A Short Course: Public Health Assessment of Genetic Tests for Screening and Prevention

    September 27-28, 2004
    Hyatt Regency Hotel ~ Atlanta, Ga


    Course Summary

    The CDC’s Office of Public Health Genomics and the Foundation for Blood Research co-organized a short course to inform participants about systematic approaches for evidence-based assessment of genetic tests.  The content was developed to be useful to public health and health care professionals, policy makers, and others who are involved in the development, evaluation, utilization, regulation, and reimbursement of genetic tests for screening and prevention.  Speakers addressed issues related to pre- and post-market evaluation of genetic tests, and included case studies and lessons learned from the CDC-sponsored ACCE Project and other review processes.The more than 60 professionals from the United States, Canada, the United Kingdom and the Netherlands who attended the short course were from state and Federal public health agencies, health care practice, health care provider organizations, industry, voluntary health organizations and advocacy groups, academic centers, and health technology assessment centers.

    Course Agenda

    Monday, September 27
    8:30 - 8:45 am Welcome and Aims of the Short Course

    Muin Khoury
    Print[PDF 360 KB]
    | PPT[10.4 MB]

    8:45 - 9:15 am Issues Surrounding Genetic Testing Linda Bradley
    Print[PDF 1.1 MB]
    | PPT[8.6 MB]
    9:15 – 9:45 am

    Epidemiologic Foundation for the Assessment of Genetic Tests

    Julian Little
    Print[PDF 135 KB]
    | PPT[297 KB]
    9:45 – 10:15 am

    The ACCE Model Process

    James Haddow
    Print[PDF 3.7 MB]
    | PPT[339 KB]
    10:15 – 10:30 am Break

    Disorder and Setting
    10:30–11:00 am Disorder/Setting Workshop: Break-out groups (Group designated by the color dot on your name tag)  
    11:00-11:15 am Disorder/Setting: Discussion and
    Glenn E. Palomaki
    Analytic Validity
    11:15 - 12:00
    Analytic Validity: HFE , CFTR & Factor V Leiden Testing Glenn E. Palomaki
    Print[PDF 6 MB]
    | PPT[315 KB]
    12:00 - 1:15 pm
    Clinical Validity
    1:15 - 1:45 pm

    Cystic Fibrosis Carrier Testing

    Sue Richards
    Print[PDF 258 KB]
    | PPT[234 KB]

    1:45 - 2:15 pm

    BRCA 1/2 Mutations and Breast Cancer:
    An Integrated Approach Using Four Epidemiologic Parameters

    Monica McClain
    Print[PDF 1.2 MB]
    | PPT[2 MB]
    2:15 - 2:45 pm A Breast/Ovarian Cancer Dataset Glenn E. Palomaki
    Print[PDF 1.2 MB]
    | PPT[1.4 MB]
    2:45 - 3:00 pm

    Colorectal Cancer Testing

    Sue Richards
    3:00 - 3:15 pm Questions

    3:15 - 3:30 Break

    Clinical Utility
    3:30 - 4:00 pm Clinical Utility Overview Glenn E. Palomaki
    Print[PDF 93 KB]
    | PPT[198 KB]
    4:00 - 4:30 pm Evaluating the Health Outcomes from Newborn Screening for Cystic Fibrosis

    Scott Grosse
    Print[PDF 502 KB]
    | PPT[482 KB]
    4:30 - 5:00 pm Family Health History as a Screening Tool for Public Health and Preventive Medicine Paula Yoon
    Print[PDF 618 KB]
    | PPT[6.1 MB]


Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd.
    Atlanta, GA 30333 USA
    800-CDC-INFO (800-232-4636)
  • Additional information for Public Health Genomics is available on our contact page. The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #